PL3247805T3 - Sposób oceny odpowiedzi pacjentów z ataksją-teleangiektazją na leczenie glukokortykoidami - Google Patents
Sposób oceny odpowiedzi pacjentów z ataksją-teleangiektazją na leczenie glukokortykoidamiInfo
- Publication number
- PL3247805T3 PL3247805T3 PL16709121T PL16709121T PL3247805T3 PL 3247805 T3 PL3247805 T3 PL 3247805T3 PL 16709121 T PL16709121 T PL 16709121T PL 16709121 T PL16709121 T PL 16709121T PL 3247805 T3 PL3247805 T3 PL 3247805T3
- Authority
- PL
- Poland
- Prior art keywords
- evaluating
- response
- ataxia telangiectasia
- glucocorticoids treatment
- patients
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM20150022 | 2015-01-19 | ||
| PCT/IB2016/050238 WO2016116850A1 (en) | 2015-01-19 | 2016-01-19 | Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment |
| EP16709121.4A EP3247805B1 (en) | 2015-01-19 | 2016-01-19 | Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3247805T3 true PL3247805T3 (pl) | 2019-12-31 |
Family
ID=52574385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16709121T PL3247805T3 (pl) | 2015-01-19 | 2016-01-19 | Sposób oceny odpowiedzi pacjentów z ataksją-teleangiektazją na leczenie glukokortykoidami |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10619208B2 (pl) |
| EP (1) | EP3247805B1 (pl) |
| JP (1) | JP6359196B2 (pl) |
| CN (1) | CN107532201B (pl) |
| AU (1) | AU2016209976B2 (pl) |
| CA (1) | CA2974181C (pl) |
| ES (1) | ES2732739T3 (pl) |
| PL (1) | PL3247805T3 (pl) |
| WO (1) | WO2016116850A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018112409A1 (en) * | 2016-12-15 | 2018-06-21 | Recursion Pharmaceuticals, Inc. | Methods of treating ataxia-telangiectasia |
| US12152274B2 (en) | 2017-09-29 | 2024-11-26 | Pharmabio Corporation | Quality management method for regeneration medical product or the like by using standardized expression amount |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5858661A (en) * | 1995-05-16 | 1999-01-12 | Ramot-University Authority For Applied Research And Industrial Development | Ataxia-telangiectasia gene and its genomic organization |
| CN101888776B (zh) * | 2007-09-20 | 2015-03-11 | 罗切斯特大学 | 治疗或预防炎性病症的方法和组合物 |
| JP2012171895A (ja) * | 2011-02-18 | 2012-09-10 | Nagoya City Univ | 毛細血管拡張性失調症治療薬及びその用途 |
| CN103031365B (zh) * | 2011-09-30 | 2014-11-26 | 益善生物技术股份有限公司 | 一种atm基因突变检测特异性引物和液相芯片 |
| CN106701709B (zh) * | 2013-05-20 | 2020-02-07 | 中南大学湘雅医院 | Atm基因突变体及其应用 |
-
2016
- 2016-01-19 CA CA2974181A patent/CA2974181C/en active Active
- 2016-01-19 AU AU2016209976A patent/AU2016209976B2/en active Active
- 2016-01-19 ES ES16709121T patent/ES2732739T3/es active Active
- 2016-01-19 WO PCT/IB2016/050238 patent/WO2016116850A1/en not_active Ceased
- 2016-01-19 US US15/544,487 patent/US10619208B2/en active Active
- 2016-01-19 JP JP2017537960A patent/JP6359196B2/ja active Active
- 2016-01-19 EP EP16709121.4A patent/EP3247805B1/en active Active
- 2016-01-19 PL PL16709121T patent/PL3247805T3/pl unknown
- 2016-01-19 CN CN201680009183.0A patent/CN107532201B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2974181C (en) | 2022-06-21 |
| WO2016116850A1 (en) | 2016-07-28 |
| EP3247805B1 (en) | 2019-03-27 |
| BR112017015527A2 (pt) | 2018-04-10 |
| CN107532201A (zh) | 2018-01-02 |
| ES2732739T3 (es) | 2019-11-25 |
| EP3247805A1 (en) | 2017-11-29 |
| AU2016209976A1 (en) | 2017-08-10 |
| US20180016637A1 (en) | 2018-01-18 |
| CN107532201B (zh) | 2021-05-11 |
| AU2016209976B2 (en) | 2021-11-11 |
| CA2974181A1 (en) | 2016-07-28 |
| JP2018503381A (ja) | 2018-02-08 |
| JP6359196B2 (ja) | 2018-07-18 |
| US10619208B2 (en) | 2020-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202006746B (en) | Methods of treatment | |
| ZA201705673B (en) | Methods for treating skin | |
| IL257561A (en) | Methods for treating inflammatory diseases | |
| IL253118A0 (en) | Methods for treating inflammatory diseases | |
| ZA201706059B (en) | Method of treatment with tradipitant | |
| GB201514760D0 (en) | Compounds and method of use | |
| GB201410116D0 (en) | Method of treatment | |
| ZA201705877B (en) | Method of treating diseases | |
| IL257764B (en) | Methods for treatment of diseases | |
| GB201706406D0 (en) | Method of treatment | |
| EP3684342C0 (en) | TREATMENT PROCEDURES | |
| GB201815588D0 (en) | Method of treatment | |
| IL253847A0 (en) | Methods of treating diseases | |
| ZA201705847B (en) | Treatment of pain | |
| IL253028B (en) | treatment method | |
| GB201511799D0 (en) | Composition and methods of treatment | |
| SG11202005850VA (en) | Methods of treatment of hypertrigl yceridemia | |
| GB201602802D0 (en) | Method of treatment | |
| GB201515244D0 (en) | Treatment of inflammatory disease or condition | |
| PL3247805T3 (pl) | Sposób oceny odpowiedzi pacjentów z ataksją-teleangiektazją na leczenie glukokortykoidami | |
| IL255012A0 (en) | Preparations and methods for treating skin conditions | |
| GB201512139D0 (en) | Methods of treatment | |
| GB201500555D0 (en) | Method and device for the treatment of diseases | |
| GB201720439D0 (en) | Method of treatment | |
| GB201718589D0 (en) | Method of treatment |